Publication | Closed Access

An improved 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction assay for evaluating the viability of Escherichia coli cells

Antimicrobial SusceptibilityHealth SciencesBiochemistryPathogen DetectionBioanalysisEscherichia Coli CellsTetrazolium BromideAntimicrobial ChemotherapyMicrobiologyAntibacterial AgentAntimicrobial CompoundMedicineAntimicrobial ResistanceDrug Resistance